Professor, Neurology, University of Alabama School of Medicine
Neurology
Dr. Peter A. King, MD
Peter A. King works in the field of Neurology. He researched medicine at Duke University School of Medicine. Duke University School of Medicine is one of the top medical schools in the US. Duke University School of Medicine has a rank of 8 in research and a 29 in primary care Peter King is a published doctor. He has 47 papers published. The most current publication "HuR, a novel target of anti-Hu antibodies, is expressed in non-neural tissues."
Publications
- Smads as muscle biomarkers in amyotrophic lateral sclerosis.
- Hu Antigen R (HuR) is a Positive Regulator of RNA Binding Proteins TDP-43 and FUS/TLS: Implications for Amyotrophic Lateral Sclerosis.
- Role of KSRP in Control of Type I Interferon and Cytokine Expression.
- Expression of PRMT5 correlates with malignant grade in gliomas and plays a pivotal role in tumor growth in vitro.
- Mutant tristetraprolin: a potent inhibitor of malignant glioma cell growth.
- Epidemiological features of amyotrophic lateral sclerosis in a large clinic-based African American population.
- KSRP: A checkpoint for inflammatory cytokine production in astrocytes.
- Phosphoregulation of the RNA-binding protein HuR by CDK5 Affects Centrosome Function.
- Electromyography tests in patients with implanted cardiac devices are safe regardless of magnet placement.
- Dermatomyositis and concomitant overlap myasthenic syndrome: A rare presentation.
- The RNA-Binding Protein HuR Promotes Glioma Growth and Treatment Resistance.
- Amyotrophic lateral sclerosis-linked mutant SOD1 sequesters Hu antigen R (HuR) and TIA-1-related protein (TIAR): implications for impaired post-transcriptional regulat...
- Alterations in RNA-binding activities of IRES-regulatory proteins as a mechanism for physiological variability and pathological dysregulation of IGF-IR translational c...
- Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells.
- Mutant Cu/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression.
- Docking and rolling, a model of how the mitotic motor Eg5 works.
- IL-1beta induces stabilization of IL-8 mRNA in malignant breast cancer cells via the 3' untranslated region: Involvement of divergent RNA-binding factors HuR, KSRP and...
- Tumor necrosis factor alpha induces angiogenic factor up-regulation in malignant glioma cells: a role for RNA stabilization and HuR.
- Stepping and stretching. How kinesin uses internal strain to walk processively.
- Measuring kinesin's first step.
- Human cytomegalovirus infection and expression in human malignant glioma.
- Porphyria presenting with bilateral radial motor neuropathy: evidence of a novel gene mutation.
- Causes of death in hospitalized adults with a premortem diagnosis of tuberculosis: an autopsy study.
- MRI reveals multiple reversible cerebral lesions in an attack of acute intermittent porphyria.
- Charcot-Marie-Tooth phenotype produced by a duplicated PMP22 gene as part of a 17p trisomy-translocation to the X chromosome.
- Expression of Hel-N1 and Hel-N2 in small-cell lung carcinoma.
- Hel-N2: a novel isoform of Hel-N1 which is conserved in rat neural tissue and produced in early embryogenesis.
- Neuron-specific hel-N1 and HuD as novel molecular markers of neuroblastoma: a correlation of HuD messenger RNA levels with favorable prognostic features.
- Cloning the 5'' flanking region of neuron-specific Hel-N1: evidence for positive regulatory elements governing cell-specific transcription.
- Hel-N1: an autoimmune RNA-binding protein with specificity for 3' uridylate-rich untranslated regions of growth factor mRNAs.
- Localization of HuC (ELAVL3) to chromosome 19p13.2 by fluorescence in situ hybridization utilizing a novel tyramide labeling technique.
- Anti-Hu antibody neuropathy: a clinical, electrophysiological, and pathological study.
- Mammalian homologs of Drosophila ELAV localized to a neuronal subset can bind in vitro to the 3' UTR of mRNA encoding the Id transcriptional repressor.
- Autoantibodies against the Hel-N1 RNA-binding protein among patients with lung carcinoma: an association with type I anti-neuronal nuclear antibodies.
- Differential expression of the neuroendocrine genes Hel-N1 and HuD in small-cell lung carcinoma: evidence for down-regulation of HuD in the variant phenotype.
- Localization of human elav-like neuronal protein 1 (Hel-N1) on chromosome 9p21 by chromosome microdissection polymerase chain reaction and fluorescence in situ hybridi...
- Analysis of the 5'' end of the mouse Elavl1 (mHuA) gene reveals a transcriptional regulatory element and evidence for conserved genomic organization.
- Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells.
- Hu antigen specificities of ANNA-I autoantibodies in paraneoplastic neurological disease.
- HuR, a novel target of anti-Hu antibodies, is expressed in non-neural tissues.
- RNA-binding analyses of HuC and HuD with the VEGF and c-myc 3''-untranslated regions using a novel ELISA-based assay.
- ATP reorients the neck linker of kinesin in two sequential steps.
- HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3' untranslated regions of cytokine and ...
- Novel DNA-binding properties of the RNA-binding protein TIAR.
- The ELAV RNA-stability factor HuR binds the 5''-untranslated region of the human IGF-IR transcript and differentially represses cap-dependent and IRES-mediated transla...
- Mutant copper-zinc superoxide dismutase associated with amyotrophic lateral sclerosis binds to adenine/uridine-rich stability elements in the vascular endothelial grow...
Schools
State University of New York At Buffalo
Deaconess Hospital
Mt Sinai Med Center
Doctors Specialties
- Emergency Medicine
- Neurology
Accepted Insurances
Education
-
Duke University Hospital -
Case Western Reserve University - University Hospitals -
Duke University School of Medicine
Hospital
-
Birmingham Veterans Affairs Medical Center -
University of Alabama Hospital
Drug Facts
| NPI NUMBER | 1780612838 | |
| NPPES Provider LastName | KING | |
| NPPES Provider FirstName | PETER | |
| NPPES Provider ZIPCode | 35233 | |
| NPPES Provider State | AL | |
| Specialty Description | Neurology | |
| Total Claim Count | 112.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 13.0 | |
| Percent Opioid Claims | 11.61 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1780612838 |
| Last Name Of The Provider | KING |
| First Name Of The Provider | PETER |
| View All |
Similar Doctors
|
Dr. Julian A. Bragg, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric A. Awad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gavin F. Brown, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ramesh Kumar, MD |
|
|
Dr. Christopher S. Russell, MD |
|
|
Dr. Hiba Arif, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason R. Holmes, MD |
|
|
Dr. Saila R. Upadhyayula, MD
This Doctor is OpenDoctor Recommended.
|